Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EONS 2021 | Novel cancer care strategies driven by the COVID-19 pandemic

Johan De Munter • 23 Sep 2021
EONS 2021
General

Johan De Munter, RN, University Hospital Ghent, Ghent, Belgium, elaborates on the impact of the COVID-19 pandemic on the implementation of novel cancer care strategies. The pandemic has highlighted new ways to approach cancer care. For instance, since the pandemic, there has been an increase in the number of cancer care services delivered at home. Therefore, it is important to develop new technologies to monitor, inform and support patients from home to maintain a high-quality standard of cancer care. There is ongoing research investigating the use of innovating technologies and involving patients in thinking about ways to improve cancer care. This interview took place at the European Society for Medical Oncology (ESMO) 2021 congress.

More from Johan De Munter

Improving opportunities for young cancer nurses
1:33
Improving opportunities for young cancer nurses
Johan De Munter • 23 Sep 2021
Improving cancer care after the COVID-19 pandemic
4:22
Improving cancer care after the COVID-19 pandemic
Johan De Munter • 23 Sep 2021
Adolescents, young adults and parents of children with cancer: supportive care
3:40
Adolescents, young adults and parents of children with cancer: supportive care
Johan De Munter • 16 Sep 2020
EONS: what can we look forward to?
2:53
EONS: what can we look forward to?
Johan De Munter • 16 Sep 2020

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals